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Outcome of Surgery for Vascular Access in Patients
Commencing Haemodialysis
C. M. Fisher and M. L. Neale
Department of Vascular Surgery, Royal North Shore Hospital, St Leonards 2065, Australia
Objective: assessment of surgical vascular access procedures for haemodialysis.
Design: retrospective cohort audit.
Materials and Methods: secondary patency was calculated from surgery until access failure, death, transplant, conver-
sion to peritoneal dialysis, or loss to follow-up. All surgical procedures including immediate failures and failures to mature
fistulae were included but not radiological interventions.
Results: four hundred and forty-five operations were undertaken in 197 patients over 87 months comprising 273 access
creations and 172 revisions. Median follow-up was 26 months with a mortality of 9.4 deaths per 100 patient-years
including eight perioperative deaths. Autogenous access was created in 147 (75%) patients with 142 based on the radial
artery whilst 50 prosthetic grafts including 46 PTFE grafts and 40 forearm loops were placed. Patients receiving grafts were
more likely to be older, female and die in follow-up. Grafts had higher patencies of 89, 75 and 68% at 1, 2 and 4 years,
respectively compared to 69, 63 and 55% for autogenous access. This difference was significant (p 0.049) when the effects
of the presence of diabetes and peripheral arterial disease were accounted for but more frequent revisions were required. The
final access placed was autogenous in 110 (56%) and prosthetic in 87 (44%) patients.
Conclusions: in our surgical unit, there was high secondary patency including for prosthetic grafts, high autogenous
utilisation and relatively infrequent reintervention.
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Introduction
The requirement for haemodialysis services is increas-
ing by approximately 7% per annum.1 Creation and
maintenance of haemodialysis access consume a con-
siderable portion of resources used in the manage-
ment of chronic renal failure as well as accounting
for up to one-third of admissions. The aim of this
study was to determine the outcome of surgical
procedures undertaken for haemodialysis access in a
single vascular surgical Unit.
Methods
The primary and secondary patencies of consecutive
new adult referrals for haemodialysis accesses estab-
lished by a vascular surgical unit within a tertiary
referral hospital were reviewed. A single senior vas-
cular surgeon undertook or supervised all surgery
for the first 75 months of the review period from
1 January 1994. A second senior surgeon within the
unit also undertook vascular access surgery for the
12 months before the close of the review period on
31 March 2001.
Patient and operative details were obtained from
the Unit database with additional and follow-up
data obtained as required from the Australia and
New Zealand Renal Registry (ANZDATA), hospital
medical records and the specialist's records. All
required records were obtained for review. Conduct
of this review was approved by the Institutional Ethics
Committee.
The policy for the establishment of access was for an
arteriovenous fistula to be created whenever possible
in the non-dominant forearm. When on clinical assess-
ment, the cephalic vein in the forearm was unsuitable
for anastomosis, unlikely to mature or the radial
artery pulse was absent, alternative access was con-
sidered. Generally, this was placement of a prosthetic
graft in the non-dominant forearm but in selected
cases, the upper arm or dominant forearm was used
for creation of a fistula. Saphenous vein grafts were
used occasionally in the early and middle period of
the review period but were abandoned because
of a perceived high rate of subsequent stenosis
and occlusion compared to both direct fistulae and
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prosthetic grafts, the initial requirement for general
rather than regional or local anaesthesia and the add-
itional patient discomfort of the vein harvest site.
Access in the thigh was placed as a loop in the mid-
thigh to the superficial femoral vessels with all inci-
sions well clear of the groin. In patients expected to
require self-cannulation, access was always placed in
the non-dominant forearm even if this required place-
ment of a prosthetic graft in the forearm rather than a
fistula in the upper arm. The potential for earlier util-
isation of grafts compared to fistulae was not consid-
ered in the decision as to the type of access placed. The
decision to place further access, and the site and type
of access were made on a patient by patient basis
without a formal clinical pathway.
Preoperative assessment with ultrasound of the
forearm, cubital fossa and subclavian veins was not
routinely undertaken. A small number of highly
selected patients in whom clinical examination was
unable to identify suitable cubital fossa veins under-
went duplex scanning to assess the superficial veins of
the cubital fossa and upper arm. Examination of the
central veins was only undertaken if there was a his-
tory of central venous cannulation and symptoms or
signs suggestive of central venous stenosis or occlu-
sion. All haemodialysis access procedures were
undertaken with the intention of creating or maintain-
ing long-term haemodialysis access and none were
undertaken for temporary access.
Patients not yet on haemodialysis received between
2500±5000 IU unfractionated heparin intra-operatively
depending on their weight and patients already on
haemodialysis via temporary catheters between 0
and 5000 IU heparin. Post-operatively, patients not
yet on dialysis generally took low-dose aspirin until
haemodialysis commenced. Preoperative screening
for thrombophilic states was not routinely undertaken
but patients with subsequent recurrent unexplained
access thrombosis were screened for thrombophilic
states and selectively anticoagulated. Antibiotic
prophylaxis was a single dose of 1 g of cephalothin
at the time of surgery with vancomycin used in
patients receiving prosthetic grafts with temporary
central venous catheters present at the time of surgery
or a significant history of adverse response to
cephalosporins.
Following surgery, patients with clinically adequate
access commenced haemodialysis without further
imaging. Patients with autogenous access thought to
be unsuitable or unable to be accessed underwent
progress clinical assessments and fistulography to
help decide whether to attempt revision or abandon
that access. Patients on haemodialysis with low flow
or high venous pressures were also referred for
angiography to determine if a correctable lesion was
present. There was no policy of routine screening of
accesses with duplex scanning or other investigations.
Only web-like stenoses were thought to be suitable for
balloon dilatation. Diffuse stenosis at the venous anas-
tomosis thought to be due to intimal hyperplasia was
treated surgically with either patch angioplasty or
extension of the graft to proximal veins. After access
thrombosis, the decision to attempt salvage or aban-
don the access and construct new access was clinically
based. Further intervention was usually surgical
rather than radiological. Thrombolysis was rarely
undertaken and only after the cause for the throm-
bosis had been identified and reversed or eliminated.
Accesses were classified and patencies analysed
using categories and methods very similar to the
recently published US reporting guidelines for vas-
cular access. Secondary patency was defined as the
maintenance of haemodialysis access adequate to sus-
tain effective haemodialysis. Accesses that occluded
and in which patency was unable to be reestablished,
failed to mature, failed immediately, became unable
to be cannulated or required substantial replacement
were deemed to have failed. Patency was measured
from the date of creation of the access to the date of
failure with the assessment of patency censored by
transplantation (successful or otherwise), death, with-
drawal from dialysis, conversion to peritoneal dialysis
(CAPD), transfer to other surgical Units or loss to
follow-up. All surgical interventions undertaken
were included in the review and analysed separately
including immediate failures and procedures to
superficialise veins. Multiple procedures within a
single operation were counted as a single operation
but returns to theatre on the day of surgery were
analysed as additional procedures ie failed primary
patency.
Accesses electively closed after transfer to CAPD or
successful transplant were already censored and
therefore were not defined as failures unless already
deemed so prior to censoring. If the access occluded
and patency was reestablished, even if placement of
temporary central venous access was required, then
secondary patency was defined as maintained. If the
access was substantially replaced with a long inter-
position graft, the existing access was defined as
having failed and a new access established. However,
placement of a short interposition or extension graft
was defined as maintaining the secondary patency of
the existing access.
Primary patency was defined as patency free of any
surgical intervention. Radiological interventions were
not assessed and assisted primary patency was not
determined.
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Patency rates and the association of risk factors
were calculated and compared using chi squared
and t-tests, Kaplan±Meier plots and log-rank tests
and Cox proportional hazards regression.
Results
Over 87 months from January 1994 to March 2001,
197 patients with no prior permanent haemodialysis
access were referred for the establishment of per-
manent vascular access. Overall, 273 accesses were
placed and 172 revision procedures undertaken. The
total follow-up was 426 patient-years, with a mean
(median, interquartile range) follow-up of 26 (21, 7±38)
months per patient. Nine patients underwent their
initial surgery within three months of study closure,
109 (55%) patients were censored by closure of the
review period, 40 (20%) patients died, 25 (14%) under-
went transplantation, four (2%) patients converted to
CAPD and 19 (10%) transferred to other haemodialy-
sis units or were lost to follow-up. There were four
deaths within 30 days of the patient's first operation to
establish access and a further four following sub-
sequent operations, giving a perioperative mortality
of 2.0% for the patient's initial procedure and an over-
all perioperative mortality of 1.8%. The overall patient
survival is shown in Figure 1.
The mean (median, interquartile range) age at initial
surgery over the study period was 61 years (65, 51±73).
The minimum age was 18 years and the maximum
was 88. In the ANZ Renal Registry, the mean (median)
age at commencement of haemodialysis in 1994 in
New South Wales was 54 (58) years, and in 1999, 58
(61) years. The average age at surgery in our Unit each
year has been consistently greater than the average
age of commencement of haemodialysis in NSW
between 1993 and 2001 with a mean (median) differ-
ence of 5.5 (5.3) years (Fig. 2).
Fifty-eight percent of patients were male. Comor-
bidities defined according to ANZDATA criteria were
recorded at initial surgery in 193 patients. Chronic
obstructive airways disease (COAD) was present in
10%, coronary artery disease (IHD) in 42%, peripheral
vascular arterial disease (PVD) in 20%, cerebrovascu-
lar disease in 12% and hypertension (HT) in 90%.
Diabetes was present in 23%; comprising 7% non-
insulin dependent diabetics managed with diet or
oral hypoglycaemic agents, 7% non-insulin dependent
diabetes managed with insulin and 9% insulin
dependent diabetics.
Increased age, IHD, PVD, prosthetic graft use and
COAD were all associated with subsequent mortality
on univariate analysis but on multivariate analysis,
only age was associated with subsequent mortality
(Table 1) with a more than doubling of risk of mortal-
ity per decade of age.
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Fig. 1. Kaplan±Meier plot showing patient survival. Censored
patients shown (). Data points shown for SE510% and six or
more patients.
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Fig. 2. Median age at surgery for patients commencing haemo-
dialysis in our review (^) compared to median age when
commencing haemodialysis in NSW in ANZDATA (°)
Table 1. Univariate and multivariate analysis of factors associated
with patient mortality.
Hazard ratio 95% CI p
Univariate
Age (per decade) 2.16 1.51±3.05 50.001
PVD 2.23 1.16±4.28 0.016
IHD 2.18 1.14±4.18 0.018
COAD 2.42 1.14±5.14 0.021
Prosthetic graft 2.00 1.06±3.76 0.033
Cerebrovascular , sex,
hypertension, diabetes
40.10
Multivariate
Age (per decade) 2.16 1.51±3.05 50.001
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The initial access required 281 operations to estab-
lish and maintain function and the 197 patients overall
required 273 separate accesses and 445 operations.
The average number of operations per patient under-
taken was 2.1, the average number of accesses created
per patient was 1.4 and the average number of opera-
tions required per access was 1.6 (Figs 3±5). The aver-
age number of operations for the initial access was 1.4.
One hundred and forty-four patients (73%) required
establishment of only a single access and 102 (80%)
required only a single operation to establish and main-
tain that access. The 95 patients who required more
than one operation to establish access required a
further 248 operations (2.6 further operations per
patient), with the 53 patients whose first access failed
requiring a further 74 accesses (1.4 further accesses
per patient) and 164 further operations (3.1 further
operations per patient).
The secondary and primary patencies of the first
access placed are shown in Figure 6. At 60 months,
the overall primary and secondary patencies of the
first access were 29 and 55%.
Of the initial accesses placed, 147 (75%) were
autogenous and 50 were prosthetic grafts. Patients
who had prosthetic accesses initially placed were sig-
nificantly more often female, older and likely to die
in follow-up than those receiving autogenous access.
0
20
40
60
80
100
120
140
160
180
200
1 2 3 4 5 6 7+
Number of operations
Nu
m
be
r 
of
 
ac
ce
ss
es
Fig. 3. Frequency histogram of 445 operations undertaken on 273
accesses.
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Fig. 4. Frequency histogram of 273 accesses placed in 193 patients.
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Fig. 5. Frequency histogram of 445 operations undertaken on
193 patients.
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Fig. 6. Kaplan±Meier plot of secondary (---) and primary (ÐÐ)
patencies of initial accesses placed. Censored patients shown ().
Data points shown for SE5 10% and six or more five patients.
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A similar but not significant trend to be diabetic, to
have PVD and IHD (Table 2) was also present.
Of the initial accesses placed, all but five auto-
genous accesses were placed at the wrist with the
remainder in the cubital fossa. Of the 50 grafts, there
were 46 PTFE and four polyurethane grafts. Nine
grafts were placed in a straight configuration from
the wrist, one was placed as primary access in the
thigh and the remaining 40 grafts were loops from
the brachial artery. The initial and subsequent accesses
placed and final access in use are shown in Table 3;
autogenous access was present in 56% of the 197
patients with functioning access at study closure or
censoring.
In addition to the grafts initially placed that throm-
bosed, four (8%) prosthetic grafts developed infection
in the medium or longer term requiring revision
although all were salvaged by excision and local
bypass. A further two loop grafts, both in females,
developed steal sufficient to require graft closure and
one graft developed a false aneurysm requiring inter-
vention but not closure. In the further 60 grafts placed
subsequently, there were three infections requiring
surgical intervention giving an overall infection rate
of 6%, as well as the development of steal and aneur-
ysm in two other patient (Table 4).
The secondary patency of autogenous access was
less than that of prosthetic grafts; 76, 69, 63 and 55%
compared to 91, 89, 75 and 68% at 6, 12, 24 and
48 months respectively (Fig. 7), although the differ-
ence was not significant. The secondary patency was
significantly increased in the presence of diabetes
(Table 5) with a trend for reduced patency in the
presence of autogenous access. After allowance was
made for the presence of diabetes and PVD, the
Table 2. Differences in characteristics of patients initially
receiving autogenous or prosthetic access.
Factor Autogenous Prosthetic p Overall
Male 66% 36% 50.001 58%
Subsequent Mortality 16% 32% 50.001 20%
Mean Age (yrs) 59 65 0.006 61
Diabetes 20% 32% 0.07 23%
PVD 16% 28% 0.07 19%
IHD 39% 52% 0.10 42%
Hypertension 40.30 90%
Cerebrovascular  40.30 12%
COAD 40.70 10%
Table 3. Initial, subsequent and final accesses placed.
Type Initial Further Total Final
Autogenous 147 (75%) 16 (21%) 163 (60%) 110 (56%)
Direct fistula 143 10 153 104
Translocated LSV 4 6 10 6
Radial 142 12 154 103
Brachial 5 4 9 7
Prosthetic 50 (25%) 60 (79%) 110 (40%) 87 (44%)
Forearm loop 40 19 69 56
Forearm straight 9 17 26 21
Thigh loop 1 14 15 11
PTFE 46 58 104 87
Polyurethane 4 2 6 3
Total 197 76 273 197
Table 4. Development of complications in accesses requiring
revision but not necessarily excision or closure.
Complications Number at risk Rate (%)
Infection 7 110 grafts 6
Steal 3 110 grafts 3
Aneurysm 2 273 accesses 1
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Fig. 7. Kaplan±Meier plot of secondary patencies of initial accesses
placed in new referrals for dialysis comprising 50 prosthetic (---) and
147 autogenous (ÐÐ) accesses. Censored patients shown (). Data
points shown for SE5 10% and for six or more remaining accesses.
Table 5. Univariate and multivariate analysis of factors associated
with failure of access secondary patency (factor greater than 1
associated with increased failure).
Hazard ratio 95% CI p
Univariate
Diabetes 0.44 0.21±0.93 0.032
Autogenous 1.83 0.93±3.61 0.082
COAD 1.75 0.88±3.47 0.11
PVD 1.55 0.85±2.84 0.15
Sex, age, IHD,
Cerebrovascular ,
hypertension
40.25
Multivariate
Diabetes 0.39 0.18±0.84 0.016
PVD 2.07 1.11±3.85 0.023
Autogenous 2.00 1.00±3.97 0.049
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patency of prosthetic grafts compared to autogenous
access was significant (p 0.049) with the difference
in patency partly to be due to the failure of 22% of
autogenous accesses within 6 months. Failure rates of
autogenous access patent for six months or longer
were similar to prosthetic grafts. The causes of the
early autogenous failures were not formally cate-
gorised but were predominantly due to failure of
fistulae to mature. Fistulae that thrombosed early
were generally not revised when the veins were
judged to be marginal.
However, autogenous accesses required signif-
icantly (p5 0.01) fewer additional operations (0.3)
than the grafts (0.8) to maintain function. Similar
numbers of reinterventions were undertaken for
subsequent accesses. For the first accesses placed,
revisional procedures were undertaken on average
every 50 months for autogenous accesses and
18 months for grafts and for subsequent accesses,
every 17 months for autogenous access and 11 months
for grafts. Overall, after the initial operation to estab-
lish access, patients underwent further surgery on
average every 20 months.
Discussion
Comparisons of the outcomes of vascular access
patency are necessarily limited by the wide variation
in the method of reporting of results. Some studies
exclude immediate failures, fistulae failing to mature
and accesses removed because of sepsis. Others calcu-
late patency from each intervention, i.e. `` interval''
patency rather than overall secondary patency, whilst
others calculate patency from first cannulation rather
than the date of creation of the access.
Recently, formal standards and definitions have
been proposed for reports in the United States2 of
the outcomes of vascular access procedures. The
defined outcomes used in our report are generally
consistent with those and in particular the definition
of secondary patency is the same. It may be argued
that the calculation of patency from the creation of the
access, rather from the date of first cannulation, results
in an increased apparent duration of patency. How-
ever, the inclusion of all access revisions and failures
prior to the use of the access reduces the overall
patency. In our review, fistulae failing to mature
were defined as patent until they were determined to
be unable to be used for access rather than retrospect-
ively determining the date of failure as that of the
initial surgery.
Furthermore, the purpose of this study was to ana-
lyse outcome by intention to treat ie to include all
accesses placed when it was intended for the patient
to undergo haemodialysis whether or not the patient
eventually used the access. Therefore, the results of all
patients who died before their access was used,
patients undergoing transplantation and patients in
whom attempts to establish haemodialysis access are
abandoned due to thrombophilic states or sepsis are
also included. Measurement of patency from the date
of first cannulation will necessarily exclude these
patients and therefore increase apparent patency
rates. Similarly, inclusion of only those patients
recorded in Renal Registries may also exclude
accesses failing before registration. Other events such
as procedure-related death would potentially also not
be reported. Overall, these effects on patency are
reduced with longer and more complete patient
follow-up.
Access has been classified as autogenous or pros-
thetic. This includes saphenous vein grafts as autogen-
ous access. However, it may be argued that the
haemodynamics of accesses based on saphenous
vein translocated to the arm are more similar to
those using prosthetic grafts than of direct fistulae
and that these saphenous vein grafts should be
grouped with prosthetic grafts.
There have been two recent reports3,4 of the out-
comes of surgery for haemodialysis vascular access
using longitudinal data collection of a random sample
of patients. These figures should serve to illustrate
current practice and outcomes although only patients
reported to the appropriate Registry can be included
with patients undergoing access creation but under-
going transplantation, choosing not to commence dia-
lysis or dying before haemodialysis commences not
being included. Furthermore, the DOPPS study mea-
sured patency from the date of first usage, and pre-
sumably excluded all accesses failing before first use.
This study also included all patients on haemodialysis
rather than those commencing treatment.
In our series of patients referred for commencement
of haemodialysis, the secondary patency of autogen-
ous access at 3 and 4 years of 62 and 56% are com-
parable to the patencies 64±72% and 37±72% reported
between 1982 and 1996 in a recent U.K. review of
vascular access.5 However, there has been a steady
increase in the number and age patients referred for
haemodialysis with a concomitant increase in signifi-
cant comorbidities so conclusions drawn from direct
comparison of patencies with series from previous
time-periods must be cautious.
Our results at 24 months (63%) are comparable to
the 64% recently reported by the United States
Renal Dialysis System Dialysis Morbidity and
Mortality Study in a random sample of 1583 patients
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commencing haemodialysis.3 The results at two years
are similar to those in the US portion of the DOPPS
study but only one-year patency was reported for the
European portion of that report. The patient demo-
graphics seem similar to our patients. In a local
report,6 the patency of autogenous access was almost
90% but the mean age of patients at the start of
dialysis was 57 years compared to 61 at surgery in
our series, the type of access was unknown in 8.5% of
patients, the type and site of fistulae created not stated
and patients with less than three months follow-up
were not included, potentially excluding patients with
early occlusion, and death or early loss to follow-up. It
was also unclear if patients with access created but not
in use were included.
However, unlike the U.S. report, the U.K. review
and the local series, the secondary patency of pros-
thetic grafts in our report was significantly higher
than for autogenous access with secondary patencies
at 2 and 3 years of 75 and 68% compared to 60% at
2 years in the U.S. review, 40±59% at 3 years in the
U.K. review and 50 and 50% at 2 and 3 years in the
Australian report. Like the U.S. and Australian
reports, a higher rate of reintervention for grafts
compared to autogenous access was required but the
absolute rate of reintervention in our series was sub-
stantially lower; despite the mean follow-up being
more than double and losses to follow-up half that of
the U.S. series, patients required a comparable aver-
age number of accesses (1.4 compared to 1.4) and
fewer revisions (0.9 compared to 1.2). Furthermore,
although the secondary patency of autogenous access
in our series was only slightly lower than in the US
study, the fistula creation rate was substantially
greater at almost 75% compared to 30%. Despite the
early failure of 22% of autogenous accesses, the final
access used was autogenous in 56% of patients and
almost all of these were radiocephalic fistulae. The
final access used was not reported in the U.S. series,
although it is reported that overall 181 (26%) of the
672 fistulae created were vein transpositions whilst in
our series all but 10 of the 163 autogenous accesses
created were direct fistulae.
In the DOPPS study, although there was a high rate
of autogenous use, the location of the access was not
stated and patency was only assessed from first use
rather than from the date of surgery. In our series,
autogenous accesses remaining patent for more than
3 months had a very low subsequent failure rate. We
hypothesise that the patency of our autogenous access
would have been similar to the DOPPS study if a
similar method of assessment of had been used.
It has been our practice to attempt to create a radio-
cephalic fistula whenever considered possible. Whilst
it may be argued that the early failure of almost 20%
of autogenous accesses, principally radiocephalic
fistulae perhaps represents an over-optimistic choice
of first procedure or vessel, the final proportion of
patients using radiocephalic fistulae as their access is
very high at over 50% of all patients. We contend that
the attempted creation of a fistula carries little mortal-
ity and morbidity. If the outcome of these fistulae
could be better predicted then initial autogenous
access in an alternate site could presumably be cre-
ated. However, in Australia, the rate of home haemo-
dialysis is approximately 15% with an absolute
requirement for ease of access with cannulation in
either the non-dominant forearm or dominant thigh.
Furthermore, it is felt that cannulation is easier and
patient comfort better with access in the forearm, even
in satellite haemodialysis units, although we have no
objective data to support this contention. However, in
our experience the creation of access using a pros-
thetic loop in the forearm, when it is judged that a
radiocephalic fistula is unsuitable, appears reasonable
given the high patency and low infection rates of the
prosthetic grafts placed in our experience. We do
accept that there will be a higher rate of reintervention
required to maintain patency for these grafts but
argue that should these patients have had autogenous
access based on the brachial artery, there would be a
higher rate of reintervention for venous aneurysm
formation and steal than those accesses based on the
radial artery.
Perhaps it is now appropriate to undertake a
randomised trial to determine the most effective
haemodialysis access if a radiocephalic fistula is
judged unsuitable or has failed.
Grafts placed in the thigh in our study were anasto-
mosed to the superficial femoral artery and vein in the
mid-thigh rather than in the inguinal area. We believe
that this approach reduces the rate and minimises the
complications of sepsis by increasing the distance of
the access and of the cannulation site from the groin.
Whilst radiological interventions such as angio-
plasty and thrombolysis have been used to maintain
or salvage the patency of haemodialysis access, these
procedures were not included in this analysis as the
general policy of intervention in this Unit was for
surgical interventions. Few radiological interventions
were undertaken, and these were generally not
initiated by the surgical team. The perception was
that the success of radiological procedures alone was
very modest and usually required subsequent surgical
intervention within a short period so there would be
little or no difference in the duration of secondary
patency but an increase in the number of interventions
required to maintain patency.
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Other interventions proposed to increase access
patency are not currently routinely undertaken in our
Unit. It has been proposed7 that preoperative duplex
scanning improved outcomes by detecting occult
proximal major vein stenoses and increasing autogen-
ous access utilisation. However, even after the adoption
of this approach, the fistulae utilisation and patency of
that group was still less than in our report. Hypercoa-
gulable or prothrombotic states are reported to occur in
a high proportion of patients receiving haemodialysis.8
As well as retrospectively suspecting patients of being
hypercoagulable by otherwise unexplained access
thrombosis, preoperative screening may also identify
these patients. However, the precise conditions to
screen for given the cost and variety of tests available
isunclearas is the subsequentappropriatemanagement
once an abnormality is detected.
In our surgical Unit over an extended period, there
was high autogenous utilisation, relatively infrequent
reintervention and high secondary patency including
for prosthetic grafts. We believe that a well function-
ing radiocephalic fistula provides the ideal access for
haemodialysis, the site and type of the next best access
is less clear and further research is required.
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